These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7510813

  • 1. Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation.
    Gisselbrecht C, Prentice HG, Bacigalupo A, Biron P, Milpied N, Rubie H, Cunningham D, Legros M, Pico JL, Linch DC.
    Lancet; 1994 Mar 19; 343(8899):696-700. PubMed ID: 7510813
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lenograstim: a review of its use in chemotherapy-induced neutropenia, for acceleration of neutrophil recovery following haematopoietic stem cell transplantation and in peripheral blood stem cell mobilization.
    Keating GM.
    Drugs; 2011 Apr 16; 71(6):679-707. PubMed ID: 21504247
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group.
    Dombret H, Chastang C, Fenaux P, Reiffers J, Bordessoule D, Bouabdallah R, Mandelli F, Ferrant A, Auzanneau G, Tilly H.
    N Engl J Med; 1995 Jun 22; 332(25):1678-83. PubMed ID: 7539109
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial.
    Schmitz N, Ljungman P, Cordonnier C, Kempf C, Linkesch W, Alegre A, Solano C, Simonsson B, Sonnen R, Diehl V, Fischer T, Caballero D, Littlewood T, Noppeney R, Schafhausen P, Jost L, Delabarre F, Marcus R.
    Bone Marrow Transplant; 2004 Dec 22; 34(11):955-62. PubMed ID: 15489865
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
    Takeshita A, Saito H, Toyama K, Horiuchi A, Kuriya S, Furusawa S, Tsuruoka N, Takiguchi T, Matsuda T, Utsumi M, Shiku H, Matsui T, Egami K, Tamura K, Ohno R.
    Int J Hematol; 2000 Feb 22; 71(2):136-43. PubMed ID: 10745623
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients.
    Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HM, Link H, Zander A, Barge A.
    Lancet; 1996 Feb 10; 347(8998):353-7. PubMed ID: 8598700
    [Abstract] [Full Text] [Related]

  • 15. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer.
    Nemunaitis J, Rabinowe SN, Singer JW, Bierman PJ, Vose JM, Freedman AS, Onetto N, Gillis S, Oette D, Gold M.
    N Engl J Med; 1991 Jun 20; 324(25):1773-8. PubMed ID: 1903847
    [Abstract] [Full Text] [Related]

  • 16. A European phase II study of recombinant human granulocyte colony-stimulating factor (lenograstim) in the treatment of severe chronic neutropenia in children. Lenograstim Study Group.
    Donadieu J, Boutard P, Bernatowska E, Tchernia G, Couillaud G, Philippe N, Le Gall E.
    Eur J Pediatr; 1997 Sep 20; 156(9):693-700. PubMed ID: 9296532
    [Abstract] [Full Text] [Related]

  • 17. Comparison of lenograstim and filgrastim on haematological effects after autologous peripheral blood stem cell transplantation with high-dose chemotherapy.
    Kim IH, Park SK, Suh OK, Oh JM.
    Curr Med Res Opin; 2003 Sep 20; 19(8):753-9. PubMed ID: 14687447
    [Abstract] [Full Text] [Related]

  • 18. Clinical benefits of lenograstim in patients with neutropenia due to chemotherapy for multiple myeloma (MM).
    Takagi T, Sawamura M, Sezaki T, Kashimura M, Tsuchiya J, Hotta T, Ogawa N, Hirashima K.
    Support Care Cancer; 2001 Jul 20; 9(5):397-9. PubMed ID: 11497396
    [Abstract] [Full Text] [Related]

  • 19. Results and follow-up of a phase III randomized study of recombinant human-granulocyte stimulating factor as support for immunosuppressive therapy in patients with severe aplastic anaemia.
    Gluckman E, Rokicka-Milewska R, Hann I, Nikiforakis E, Tavakoli F, Cohen-Scali S, Bacigalupo A, European Group for Blood and Marrow Transplantation Working Party for Severe Aplastic Anemia.
    Br J Haematol; 2002 Dec 20; 119(4):1075-82. PubMed ID: 12472591
    [Abstract] [Full Text] [Related]

  • 20. Prospective randomized comparative observation of single- versus split-dose lenograstim to enhance engraftment after autologous stem cell transplantation in patients with multiple myeloma or non-Hodgkin's lymphoma.
    Jang G, Ko OB, Kim S, Lee DH, Huh J, Suh C.
    Transfusion; 2008 Apr 20; 48(4):640-6. PubMed ID: 18194384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.